Congruently, SPP1 was shown to recruit GAMs to mouse gliomas via αvβ5 integrin, and systemic administration of osteopontin-eliminating aptamers increased the median survival time of tumor-bearing animals by 68% [22]. The gene discussed is SPP1; the disease is neoplasm.